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INTRODUCTION
Intravenous lipid emulsions (ILEs) infusion has 
been applied in clinical practice for more than 50 
years. Its main designation was for parenteral nutri-
tion, as a source of energy and essential fatty acids in 
hospitalized adults and children (1).
The first reports about ILEs administration are 
related to reducing the toxicity of local anesthetics in 
experimental animals. Local anesthetics are wide-
ly used for topical anesthesia, infiltration anesthe-
sia, nerve block, including epidural and spinal anes-
thesia. Local-anesthetic systemic toxicity (LAST) is 
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the most dangerous complication in their application 
in medical practice. This life-threatening complica-
tion is a result of resorption or intravascular injec-
tion of the local anesthetic. The frequency of LAST is 
not high - 1:1000 (2), with clinical manifestations in-
cluding arrhythmias, seizures, changes in conscious-
ness to coma, cardiac arrest. A number of fatal cardi-
ac arrest cases have been associated with the system-
ic toxicity of local anesthetics, such as bupivacaine 
and ethidocaine (3). Often conventional treatment of 
these complications is ineffective (4).
Under experimental conditions, pretreatment 
of rats with ILEs protects bupivacaine-induced car-
diotoxic effects. It was found that administration of 
20% ILEs in rats after intravenous bolus dose admin-
istration of bupivacaine caused an increase in LD50 
from 12.5 mg/kg to 18 mg/kg compared to the con-
trol animals. All rats receiving lipid emulsion (LE) 
after a bolus dose of 15 mg/kg bupivacaine survived 
and all animals in the control group not receiving LE 
died (5).
In another experimental study, injection of bu-
pivacaine at a dose of 10mg/kg caused the death of all 
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dogs in the control group. Electrocardiogram (ECG) 
and blood pressure were normalized in animals re-
ceiving 20% of LE and they survived (6).
ILES was administered for the first time in clin-
ical practice in 2006 to treat systemic toxic effects 
caused by local anesthetics bupivacaine and mepi-
vacaine. After application of these anesthetics for a 
brachial plexus block, the electrocardiogram showed 
asystole. Heart rate and blood pressure were normal-
ized 15 seconds after intravenous administration of 
100 ml of 20% lipid solution. The patient recovered 
completely without neurological sequelae and car-
diovascular changes (7). Subsequent reports dem-
onstrate the beneficial effect of ILEs on LAST, of-
ten after unsuccessful standard resuscitation (8,9). 
Soon after administration of ropivacaine for axillary 
plexus block, a female patient experienced general-
ized tonic-clonic seizures, followed by asystole. Stan-
dard resuscitation measures were unsuccessful and 
10 minutes later she received a bolus dose of ILEs, fol-
lowed by lipid infusion. The patient restored normal 
heart rhythm, ECG and blood pressure. Four days 
later the patient was discharged from the hospital 
completely recovered (10). Five minutes after admin-
istration of bupivacaine and ropivacaine before total 
knee arthroplasty a patient experienced ventricular 
tachycardia and arterial pressure of 60/30 mm Hg, 
which were not overcome by standard performed re-
suscitation. Blood pressure was normalized and a si-
nus rhythm was recorded on the ECG 4 minutes af-
ter the patient received two bolus doses of 250ml 20% 
LE each. The patient recovered without further se-
quelae (11). A patient began to have generalized clon-
ic-tonic seizure 20 seconds after sciatic nerve block 
with bupivacaine which was controlled with mid-
azolam, followed by ventricular tachycardia that was 
not managed with amiodarone. A bolus dose of LE 
and electrical defibrillation followed by lipid infusion 
were administered. The ventricular tachycardia per-
sisted for a few minutes, and after two hours the nor-
mal neurological status was restored. The complete 
recovery of the patient and the prevention of cardio-
vascular collapse were associated with rapid admin-
istration of ILEs (12).
ILEs also restored neurological impairment 
and symptoms of LAST, including seizures and al-
tered mental status and the benefits of their appli-
cation are not limited to the cardiovascular system 
(13). The administration of ILEs to treat neurotoxici-
ty and ventricular ectopic activity effectively prevent-
ed progression to cardiac arrest (14).
After a lumbar plexus block with ropivacaine 
and lidocaine, a patient developed ventricular tachy-
cardia. ILEs were infused at the start of tachycardia, 
normal vital indications and ECG were restored very 
quickly. This allowed surgical intervention to pro-
ceed without complications (15). ILE infusion is an 
acceptable therapy for LAST resistant to standard 
therapy (16).
MECHANISM OF ILE EFFECTS
The exact mechanism of action of ILEs is 
not yet fully clarified (17,18). Most authors ac-
cept the so-called a phenomenon of “lipid sink” 
(4,5,19,20,21,22,23). Rapid administration of ILEs as 
a bolus dose creates a new, enlarged lipid phase that 
absorbs lipophilic xenobiotics and prevents their 
binding to target receptors. The resulting concen-
tration gradient causes a decrease in the concentra-
tion of the lipophilic xenobiotics in the tissues (5,21). 
Decreased serum concentration of the xenobiotic 
leads to its extraction from the tissues to the aqueous 
plasmatic phase and subsequently to the lipid phase 
(4,24), reducing its tissue toxicity (22).
The second hypothesis about the effect of ILEs 
is related to improved metabolism of cardiomyo-
cytes. Under aerobic conditions, fatty acids are the 
main energy substrate for oxidative phosphorylation 
in myocytes. That is how approximately 80-90% of 
adenosine triphosphate (ATP) is synthesized in heart 
cells (25). Local anesthetics block the transport of 
fatty acids and, respectively, their oxidation in car-
diomyocytes (26,27). ILEs increase intracellular fat-
ty acids restoring their oxidation and ATP synthe-
sis (4), thus improving myocardial contractility (28). 
However, the metabolic hypothesis does not explain 
the cerebro-protective effects of ILEs as neurons have 
limited ability to metabolize fatty acids.
According to the third hypothesis, ILEs restore 
heart function by increasing the concentration of in-
tracellular calcium. This leads to a direct positive 
inotropic effect (29) as fatty acids activate calcium 
channels (30). Probably, the three potential mech-
anisms mentioned have synergistic action after ad-
ministration of ILEs (19).
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THERAPEUTIC EFFECTS OF ILE 
ADMINISTRATION
The practical application of ILEs in LAST is 
specified in the guidelines of the Association of An-
aesthetists of Great Britain and Ireland (AAGBI), the 
American College of Medical Toxicology (ACMT) 
and the American Society of Regional Anesthe-
sia and Pain Medicine (ASRA). In case of develop-
ment of LAST, cardiopulmonary resuscitation (CPR) 
is initiated. It should not be prolonged, and should 
be followed by a bolus dose of 1.5ml/kg of Intralip-
id 20% for one minute, followed by intravenous in-
fusion of Intralipid 20% at a dose of 0.25ml/kg/min 
for 30-60 minutes. If necessary, in case of non-stabi-
lized circulation, the bolus dose is repeated twice in 
5-minute intervals. If the patient is unresponsive, the 
infusion rate should be increased to 0.5ml/kg/min. 
The infusion continues for 10 minutes upon stabi-
lization of hemodynamics. For the first 30 minutes, 
up to 10ml/kg Intralipid 20% may be applied to the 
patient (31,32,33). Some authors report the effective 
administration of lower than recommended LE dos-
es, by infusion of 10% lipid solution (34) or a short-
term infusion of 200 ml of 20% lipid solution admin-
istered after the initial regular bolus dose (35).
Following the promising results of the use of 
ILEs for the treatment of LAST, the efforts were re-
cently directed towards the use of ILEs also in cas-
es of intoxications with other lipophilic xenobiotics 
(36,37), as ILEs could be effective antidotes in acute 
exogenous intoxications with various xenobiotics 
(38). The first announcement about the effect of ILEs 
in humans beyond LAST is related to the treatment 
of severe combined oral intoxication with the anti-
depressant bupropion and the antiepileptic drug la-
motrigine (39). Ten hours after drug ingestion, the 
patient began to have seizures and cardiac arrest with 
ventricular fibrillation. CPR was initiated, which did 
not restore heart function. A bolus dose of 100 ml 
of Intralipid 20% was administered 70 minutes lat-
er, pulse appeared after one minute and the sinus 
rhythm was restored 15 minutes later.
In subsequent reports the therapeutic effect of 
ILEs in acute intoxications with calcium antagonists, 
beta blockers, tricyclic antidepressants, antipsychot-
ics (2,4,40,41,42) is demonstrated. There is no specif-
ic antidote for most of these substances (37). 
Following an oral administration of the anti-
psychotic quetiapine and antidepressant sertraline 
- a selective serotonin reuptake inhibitor, the pa-
tient’s level of consciousness deteriorated - Glasgow 
coma scale (GCS) 3 points and he became hypoten-
sive. Four hours later the patient was administered 
1.5ml/kg 20% lipid infusion in a bolus dose. Fifteen 
minutes later consciousness improved considerably - 
GCS 9 points, allowing to avoid endotracheal intuba-
tion. After 12h all vital indices were normalized (43).
After a suicidal attempt with 6000 mg of que-
tiapine, 400 mg of citalopram - a serotonin reuptake 
inhibitor antidepressant, and 45 mg of bromazepam, 
a patient became t have seizures evolving into sta-
tus epilepticus and ventricular tachycardia. Due to 
life-threatening arrhythmia and seizures, 15ml/kg 
of 20% Lipofundin were administered, followed by 
200 ml intravenous infusion over the next two hours. 
After the bolus dose, the ventricular tachycardia and 
convulsions were completely managed (35). The an-
tidote effect of ILEs in acute intoxications with que-
tiapine was also demonstrated by other authors 
(44,45).
ILEs have been successfully administered in 
acute intoxications with other neuroleptics - olan-
zapine, haloperidol. A patient with cardiac arrest af-
ter haloperidol administration is treated with ILEs 
and sinus rhythm is restored (46). ILEs are powerful 
alternative to extracorporeal methods of treatment of 
acute carbamazepine intoxications (47).
One of the few randomized, controlled clinical 
trials on the effect of ILEs in patients with drug in-
toxications indicates that ILEs significantly improve 
consciousness (GCS) and reduce blood glucose levels 
(34). Severe intoxications with tricyclic antidepres-
sants, particularly amitriptyline, are often manifest-
ed by ventricular arrhythmias, shock, and cardiac ar-
rest. They are often refractory to treatment. In such 
clinical cases beneficial response to ILE was regis-
tered (48,49,50). 
Calcium antagonists, and in particular vera-
pamil, are widely used for the treatment of hyperton-
ic disease, angina pectoris and arrhythmias. Acute 
intoxications with them are uncommon but severe 
and with high lethality (51). Cardiovascular shock 
is often refractory to treatment. In these cases, ILEs 
should be administered without delay as there are re-
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ports of their positive effect in these intoxications 
(51,52,53,54). ILEs have been successfully applied in 
acute amlodipine intoxications (55,56,57).
Beta blockers are also commonly used in clin-
ical practice to treat arterial hypertension, angina 
pectoris, heart failure, arrhythmias, migraine. ILEs 
are recommended in cardiac arrest and severe hypo-
tension, refractory to ongoing therapy. A visible pos-
itive effect in asystole and hypotension, resistant to 
other inotropic agents in poisonings with propran-
olol, bisoprolol, carvedilol, nebivolol, atenolol (41) 
and metoprolol (58) is reported. The combined in-
toxications with beta blockers and calcium antago-
nists often cause cardiogenic shock due to myocar-
dial depression and rhythm-conduction disorders. 
An additional mechanism of the ethiopathogenesis 
of shock is vasodilatation caused by calcium antago-
nists. The treatment of these severe forms of poison-
ing also includes ILEs (59,60).
Intoxications with organophosphorus pesti-
cides (OPs) take the lead as causes of fatal outcome 
in acute poisonings. Most of these pesticides are li-
posoluble. ILE infusions are a new potential method 
for the treatment of such intoxications (61,62,63). A 
patient who has swallowed parathion with a suicid-
al intention has a depressed consciousness - GCS 6 
points, ventricular tachycardia followed by ventricu-
lar fibrillation and CPR undertaken was unsuccess-
ful. Thirty minutes after the cardiac arrest, a bolus 
dose of Intralipid 20% of 1.5ml/kg was administered 
twice every two minutes. Fifteen minutes later, the 
width of the ECG QRS complex was normalized and 
the sinus rhythm was restored (64).
One of the most commonly used herbicides is 
glyphosate (Roundup). In conventional treatment-
resistant intoxications with persisting hemodynam-
ic instability, ILEs are recommended (65, 66), after 
which the patient is completely recovered and is dis-
charged from the hospital without complications. 
A clinical study (67) established the antidote effect 
of ILEs in glyphosate intoxications. None of the pa-
tients treated with 20% of LE developed arterial hy-
potension or other complications, while 41% of the 
patients in the control group developed complica-
tions. Based on these results, the authors recom-
mend ILEs as an effective treatment approach in se-
vere glyphosate intoxications.
Despite the optimistic results of these and oth-
er reports on the effects of ILEs in acute intoxications 
with liposoluble xenobiotics other than topical anes-
thetics, this method is currently recommended only 
in cardiac arrest and life-threatening toxicity (68).
CONCLUSIONS
1. ILE infusion is a new method for the effective 
treatment of LAST resistant to conventional re-
suscitation therapy.
2. Application of ILEs in acute intoxications with 
xenobiotics other than topical anesthetics is 
recommended in life-threatening complica-
tions only.
3. ILEs may be applied in every hospital and the 
method is cost effective.
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